Clinical Trial: Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Atopic Dermatitis
Study Type: INTERVENTIONAL
Official Title: A Multinational, Multicenter, Double-blind, Placebo-controlled Phase 2 Study to Evaluate Efficacy and Safety of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis
Brief Summary:
This is a multinational, multicenter, double-blind, placebo-controlled, parallel-group Phase 2, 3-arm study in adult participants with moderate to severe AD who are inadequately controlled with topical therapies or for whom such topical therapies are inadvisable and who are candidates for systemic therapy.Participants will be randomized to receive SAR444656 dose 1, SAR444656 dose 2 or matching placebo.Participants who meet inclusion/exclusion criteria will be stratified for randomization by severity of AD…
Read more